Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo

Oncology Reports

Volumn 38, Issue 2, 2017, Pages 819-828

  Hashemzaei, Mahmoud ^a,b   Far, Amin Delarami ^a,b   Yari, Arezoo ^a,b   Heravi, Reza Entezari ^b   Tabrizian, Kaveh ^a,b   Taghdisi, Seyed Mohammad ^c   Sadegh, Sarvenaz Ekhtiari ^a,b   Tsarouhas, Konstantinos ^d   Kouretas, Dimitrios ^e   Tzanakakis, George ^f   Nikitovic, Dragana ^f   Anisimov, Nikita Yurevich ^g   Spandidos, Demetrios A ^f   Tsatsakis, Aristides M ^f   Rezaee, Ramin ^h  

^a Department of Nutrition and Bromatology   (United States)

^b ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^e UNIVERSITY OF THESSALY   (Greece)

^f UNIVERSITY OF CRETE   (Greece)

^g FAR EASTERN FEDERAL UNIVERSITY   (Russian Federation)

^h MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Annexin V PI; Apoptosis; Cancer treatment; Cytotoxicity; MTT assay; Quercetin

Indexed keywords

QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT NEOPLASM; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; ANIMAL; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; GENETICS; MCF-7 CELL LINE; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MCF-7 CELLS; MICE; NEOPLASMS; QUERCETIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85021876066     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2017.5766     Document Type: Article

References (99)

1. Schnekenburger M, Dicato M and Diederich M: Plant-derived epigenetic modulators for cancer treatment and prevention. Biotechnol Adv 32: 1123-1132, 2014.
2. Butler MS, Robertson AA and Cooper MA: Natural product and natural product derived drugs in clinical trials. Nat Prod Rep 31: 1612-1661, 2014.
3. Hashemzaei M, Barani AK, Iranshahi M, Rezaee R, Tsarouhas K, Tsatsakis AM, Wilks MF and Tabrizian K: Effects of resveratrol on carbon monoxide-induced cardiotoxicity in rats. Environ Toxicol Pharmacol 46: 110-115, 2016.
4. Hashemzaei M, Entezari Heravi R, Rezaee R, Roohbakhsh A and Karimi G: Regulation of autophagy by some natural products as a potential therapeutic strategy for cardiovascular disorders. Eur J Pharmacol 802: 44-51, 2017.
5. DeVita VT Jr, Young RC and Canellos GP: Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer 35: 98-110, 1975.
6. Pisani P, Bray F and Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97: 72-81, 2002.
7. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
8. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and Bray F: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 49: 1374-1403, 2013.
9. Fridlender M, Kapulnik Y and Koltai H: Plant derived substances with anti-cancer activity: From folklore to practice. Front Plant Sci 6: 799, 2015.
10. Karikas GA: Anticancer and chemopreventing natural products: Some biochemical and therapeutic aspects. J BUON 15: 627-638, 2010.
11. Katz DL, Doughty K and Ali A: Cocoa and chocolate in human health and disease. Antioxid Redox Signal 15: 2779-2811, 2011.
12. Pandey KB and Rizvi SI: Current understanding of dietary polyphenols and their role in health and disease. Curr Nutr Food Sci 5: 249-263, 2009.
13. Pandey KB and Rizvi SI: Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2: 270-278, 2009.
14. Kühnau J: The Flavonoids. A Class of Semi-Essential Food Components: Their Role in Human Nutrition. In: World Review of Nutrition and Dietetics. Bourne GH (ed). Karger, Basel, pp117-191, 1976.
15. Scalbert A and Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr 130 (Suppl): 2073S-2085S, 2000.
16. Benbrook CM: Elevating Antioxidant Levels in Food through Organic Farming and Food Processing. An Organic Center, State of Science Review. The Organic Center for Education and Promotion, 2005.
17. Hashemzaei M, Karami SP, Delaramifar A, Sheidary A, Tabrizian K, Rezaee R, Shahsavand S, Arsene AL, Tsatsakis AM and Mohammad S: Anticancer effects of co-administration of daunorubicin and resveratrol in MOLT-4, U266 B1 and RAJI cell lines. Farmacia 64: 36-42, 2016.
18. Ramkissoon JS, Mahomoodally MF, Ahmed N and Subratty AH: Antioxidant and anti-glycation activities correlates with phenolic composition of tropical medicinal herbs. Asian Pac J Trop Med 6: 561-569, 2013.
19. Glade MJ: Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 15: 523-526, 1999.
20. Murillo G and Mehta RG: Cruciferous vegetables and cancer prevention. Nutr Cancer 41: 17-28, 2001.
21. Cronin FJ, Krebs-Smith SM, Wyse BW and Light L: Characterizing food usage by demographic variables. J Am Diet Assoc 81: 661-673, 1982.
22. Block G, Dresser CM, Hartman AM and Carroll MD: Nutrient sources in the American diet: quantitative data from the NHANES II survey. II. Macronutrients and fats. Am J Epidemiol 122: 27-40, 1985.
23. Hashemzaei M, SadeghiBonjar MA, Tabrizian K, Iranshahi M, Iranshahy M and Rezaee R: Evaluation of the analgesic effect of Umbelliprenin and Umbelliprenin-morphine co-administration on the acute, chronic and neuropathic pain. IJPER 49: 121-125, 2015.
24. Kumar S and Pandey AK: Chemistry and biological activities of flavonoids: An overview. Sci World J 2013: 162750, 2013.
25. Tabrizian K, Yaghoobi NS, Iranshahi M, Shahraki J, Rezaee R and Hashemzaei M: Auraptene consolidates memory, reverses scopolamine-disrupted memory in passive avoidance task, and ameliorates retention deficits in mice. Iran J Basic Med Sci 18: 1014-1019, 2015.
26. Nikitovic D, Tsatsakis AM, Karamanos NK and Tzanakakis GN: The effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by two osteosarcoma cell lines depends on tyrosine kinase and the estrogen receptor density. Anticancer Res 23 (1A): 459-464, 2003.
27. Yamaguchi M, Murata T, El-Rayes BF and Shoji M: The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine. Oncol Rep 34: 3304-3310, 2015.
28. Cárdenas M, Marder M, Blank VC and Roguin LP: Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines. Bioorg Med Chem 14: 2966-2971, 2006.
29. Chan FL, Choi HL, Chen ZY, Chan PS and Huang Y: Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Lett 160: 219-228, 2000.
30. Kawaii S, Tomono Y, Katase E, Ogawa K and Yano M: Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem 63: 896-899, 1999.
31. Lin P, Tian XH, Yi YS, Jiang WS, Zhou YJ and Cheng WJ: Luteolin-induced protection of H2O2-induced apoptosis in PC12 cells and the associated pathway. Mol Med Rep 12: 7699-7704, 2015.
32. Leung HW, Kuo CL, Yang WH, Lin CH and Lee HZ: Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol 534: 12-18, 2006.
33. Wu TH, Yen FL, Lin LT, Tsai TR, Lin CC and Cham TM: Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int J Pharm 346: 160-168, 2008.
34. Busch C, Burkard M, Leischner C, Lauer UM, Frank J and Venturelli S: Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics 7: 64, 2015.
35. Gilbert ER and Liu D: Flavonoids influence epigenetic-modifying enzyme activity: Structure-.function relationships and the therapeutic potential for cancer. Curr Med Chem 17: 1756-1768, 2010.
36. Erlund I: Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res 24: 851-874, 2004.
37. Jakubowicz-Gil J, Paduch R, Piersiak T, Głowniak K, Gawron A and Kandefer-Szerszeń M: The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochem Pharmacol 69: 1343-1350, 2005.
38. Ramos S: Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18: 427-442, 2007.
39. Ren MX, Deng XH, Ai F, Yuan GY and Song HY: Effect of quercetin on the proliferation of the human ovarian cancer cell line SKOV-3 in vitro. Exp Ther Med 10: 579-583, 2015.
40. Deng XH, Song HY, Zhou YF, Yuan GY and Zheng FJ: Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro. Exp Ther Med 6: 1155-1158, 2013.
41. Ren KW, Li YH, Wu G, Ren JZ, Lu HB, Li ZM and Han XW: Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int J Oncol 50: 1299-1311, 2017.
42. Chen J and Kang JH: Quercetin and trichostatin A cooperatively kill human leukemia cells. Pharmazie 60: 856-860, 2005.
43. Priego S, Feddi F, Ferrer P, Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M and Estrela JM: Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: A Bcl-2-and superoxide dismutase 2-dependent mechanism. Mol Cancer Ther 7: 3330-3342, 2008.
44. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M, et al: Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 34: 459-464, 1994.
45. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H, and Aoike A: The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260: 10-13, 1990.
46. Sharma H, Sen S and Singh N: Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol Ther 4: 949-955, 2005.
47. Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, Wei YH and Chung JG: Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 34: 296-304, 2006.
48. Gao X, Wang B, Wei X, Men K, Zheng F, Zhou Y, Zheng Y, Gou M, Huang M, Guo G, et al: Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale 4: 7021-7030, 2012.
49. Cao HH, Tse AK, Kwan HY, Yu H, Cheng CY, Su T, Fong WF, and Yu ZL: Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol 87: 424-434, 2014.
50. Spagnuolo C, Russo M, Bilotto S, Tedesco I, Laratta B and Russo GL: Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia. Ann N Y Acad Sci 1259: 95-103, 2012.
51. Araújo JR, Gonçalves P and Martel F: Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 31: 77-87, 2011.
52. Maira F, Catania A, Candido S, Russo AE, McCubrey JA, Libra M, Malaponte G and Fenga C: Molecular targeted therapy in melanoma: A way to reverse resistance to conventional drugs. Curr Drug Deliv 9: 17-29, 2012.
53. Castle JC, Loewer M, Boegel S, de Graaf J, Bender C, Tadmor AD, Boisguerin V, Bukur T, Sorn P, Paret C, et al: Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics 15: 190, 2014.
54. Westerink RHS and Ewing AG: The PC12 cell as model for neurosecretion. Acta Physiol (Oxf) 192: 273-285, 2008.
55. Mayhew EG, Lasic D, Babbar S and Martin FJ: Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int J Cancer 51: 302-309, 1992.
56. Gao F, Li L, Liu T, Hao N, Liu H, Tan L, Li H, Huang X, Peng B, Yan C, et al: Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects. Nanoscale 4: 3365-3372, 2012.
57. Tang L, Gabrielson NP, Uckun FM, Fan TM and Cheng J: Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates. Mol Pharm 10: 883-892, 2013.
58. Bądziul D, Jakubowicz-Gil J, Langner E, Rzeski W, Głowniak K and Gawron A: The effect of quercetin and imperatorin on programmed cell death induction in T98G cells in vitro. Pharmacol Rep 66: 292-300, 2014.
59. Entezari Heravi R, Hadizadeh F, Sankian M, Tavakol Afshari J, Taghdisi SM, Jafarian H and Behravan J: Novel selective Cox-2 inhibitors induce apoptosis in Caco-2 colorectal carcinoma cell line. Eur J Pharm Sci 44: 479-86, 2011.
60. Chahar MK, Sharma N, Dobhal MP and Joshi YC: Flavonoids: A versatile source of anticancer drugs. Pharmacogn Rev 5: 1-12, 2011.
61. Batra P and Sharma AK: Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech 3: 439-459, 2013.
62. Apostolou A, Stagos D, Galitsiou E, Spyrou A, Haroutounian S, Portesis N, Trizoglou I, Wallace Hayes A, Tsatsakis AM and Kouretas D: Assessment of polyphenolic content, antioxidant activity, protection against ROS-induced DNA damage and anticancer activity of Vitis vinifera stem extracts. Food Chem Toxicol 61: 60-68, 2013.
63. Sahpazidou D, Geromichalos GD, Stagos D, Apostolou A, Haroutounian SA, Tsatsakis AM, Tzanakakis GN, Hayes AW and Kouretas D: Anticarcinogenic activity of polyphenolic extracts from grape stems against breast, colon, renal and thyroid cancer cells. Toxicol Lett 230: 218-224, 2014.
64. Erlund I, Kosonen T, Alfthan G, Mäenpää J, Perttunen K, Kenraali J, Parantainen J and Aro A: Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 56: 545-553, 2000.
65. Stagos D, Apostolou A, Poulios E, Kermeliotou E, Mpatzilioti A, Kreatsouli K, Koulocheri SD, Haroutounian SA and Kouretas D: Antiangiogenic potential of grape stem extract through inhibition of vascular endothelial growth factor expression. J Physiol Pharmacol 65: 843-852, 2014.
66. Hsu CL and Yen GC: Phenolic compounds: Evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. Mol Nutr Food Res 52: 53-61, 2008.
67. Vargas AJ and Burd R: Hormesis and synergy: Pathways and mechanisms of quercetin in cancer prevention and management. Nutr Rev 68: 418-428, 2010.
68. Kuo P-C, Liu H-F and Chao J-I: Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem 279: 55875-55885, 2004.
69. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B: A model for p53-induced apoptosis. Nature 389: 300-305, 1997.
70. Yoon KA, Nakamura Y and Arakawa H: Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 49: 134-140, 2004.
71. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, et al: p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64: 2350-2356, 2004.
72. O'Connor JC, Wallace DM, O'Brien CJ and Cotter TG: A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell. Invest Ophthalmol Vis Sci 49: 4237-4244, 2008.
73. Ozaki T and Nakagawara A: p73, a sophisticated p53 family member in the cancer world. Cancer Sci 96: 729-737, 2005.
74. Chien SY, Wu YC, Chung JG, Yang JS, Lu HF, Tsou MF, Wood WG, Kuo SJ and Chen DR: Quercetin-induced apoptosis acts through mitochondrial-and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum Exp Toxicol 28: 493-503, 2009.
75. Shen X, Si Y, Wang Z, Wang J, Guo Y and Zhang X: Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signaling. Int J Mol Med 38: 619-626, 2016.
76. Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM and Chen YC: Quercetin inhibition of tumor invasion via suppressing PKC δ/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 29: 1807-1815, 2008.
77. Lee C-H, Hong H-M, Chang Y-Y and Chang W-W: Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells. Biochimie 94: 1382-1389, 2012.
78. Catanzaro D, Ragazzi E, Vianello C, Caparrotta L and Montopoli M: Effect of quercetin on cell cycle and cyclin expression in ovarian carcinoma and osteosarcoma cell lines. Nat Prod Commun 10: 1365-1368, 2015.
79. Chen X, Dong XS, Gao HY, Jiang YF, Jin YL, Chang YY, Chen LY and Wang JH: Suppression of HSP27 increases the anti tumor effects of quercetin in human leukemia U937 cells. Mol Med Rep 13: 689-696, 2016.
80. Neuhouser ML: Dietary flavonoids and cancer risk: Evidence from human population studies. Nutr Cancer 50: 1-7, 2004.
81. Li W, Liu M, Xu YF, Feng Y, Che JP, Wang GC, and Zheng JH: Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a. Oncol Rep 31: 117-124, 2014.
82. Moon JH, Eo SK, Lee JH and Park SY: Quercetin-induced autophagy flux enhances TRAIL-mediated tumor cell death. Oncol Rep 34: 375-381, 2015.
83. Seo HS, Ku JM, Choi HS, Choi YK, Woo JK, Kim M, Kim I, Na CH, Hur H, Jang BH, et al: Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells. Oncol Rep 36: 31-42, 2016.
84. Yang FQ, Liu M, Li W, Che JP, Wang GC and Zheng JH: Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA21. Mol Med Rep 11: 1085-1092, 2015.
85. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT and Lee MT: The antitumor activities of flavonoids. In Vivo 19: 895-909, 2005.
86. Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S, Wang L, Hitron A, Lee JC, Xu M, et al: Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR-2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS One 7: e47516, 2012.
87. Steiner J, Davis J, McClellan J, Enos R, Carson J, Fayad R, Nagarkatti M, Nagarkatti P, Altomare D, Creek K, et al: Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer. Cancer Biol Ther 15: 1456-1467, 2014.
88. Prasad S, Phromnoi K, Yadav VR, Chaturvedi MM and Aggarwal BB: Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med 76: 1044-1063, 2010.
89. Yang H, Landis-Piwowar KR, Chen D, Milacic V and Dou QP: Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr Protein Pept Sci 9: 227-239, 2008.
90. Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, Roat E, Bertoncelli L, Cooper EL and Cossarizza A: Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med 2011: 591356, 2011.
91. Zhou J, Fang L, Yao WX, Zhao X, Wei Y, Zhou H, Xie H, Wang LY and Chen LJ: Effect of quercetin on heat shock protein expression in HepG2 cells determined by SILAC. Zhonghua Zhong Liu Za Zhi 33: 737-741, 2011 (In Chinese).
92. Jeong JH, An JY, Kwon YT, Rhee JG and Lee YJ: Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression. J Cell Biochem 106: 73-82, 2009.
93. Mu C, Jia P, Yan Z, Liu X, Li X and Liu H: Quercetin induces cell cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2). Methods Find Exp Clin Pharmacol 29: 179-183, 2007.
94. Crespo I, Garcia-Mediavilla MV, Gutiérrez B, Sanchez-Campos S, Tuñón MJ and Gonzalez-Gallego J: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells. Br J Nutr 100: 968-976, 2008.
95. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA and Kandaswami C: The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol 13: 319-328, 2006.
96. Matsukawa Y, Nishino H, Okuyama Y, Matsui T, Matsumoto T, Matsumura S, Shimizu Y, Sowa Y and Sakai T: Effects of quercetin and/or restraint stress on formation of aberrant crypt foci induced by azoxymethane in rat colons. Oncology 54: 118-121, 1997.
97. Shan BE, Wang MX and Li RQ: Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 27: 604-612, 2009.
98. Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, Leung D, Newmark H, Steele VE, Kelloff GJ and Lipkin M: Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 21: 1655-1660, 2000.
99. Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, Baker J and Kerr DJ: Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2: 659-668, 1996.